Arşiv logosu
  • Türkçe
  • English
  • Giriş
    Yeni kullanıcı mısınız? Kayıt için tıklayın. Şifrenizi mi unuttunuz?
Arşiv logosu
  • Koleksiyonlar
  • Sistem İçeriği
  • Analiz
  • Talep/Soru
  • Türkçe
  • English
  • Giriş
    Yeni kullanıcı mısınız? Kayıt için tıklayın. Şifrenizi mi unuttunuz?
  1. Ana Sayfa
  2. Yazara Göre Listele

Yazar "Erkan, Melih E." seçeneğine göre listele

Listeleniyor 1 - 1 / 1
Sayfa Başına Sonuç
Sıralama seçenekleri
  • Yükleniyor...
    Küçük Resim
    Öğe
    The role of Ga-68-DOTA-TATE PET/CT scanning in the evaluation of patients with multiple myeloma: preliminary results
    (Lippincott Williams & Wilkins, 2017) Sönmezoğlu, Kerim; Vatankulu, Betül; Elverdi, Tuğrul; Akyel, Reşit; Erkan, Melih E.; Halaç, Metin; Aydın, Yıldız
    ObjectiveIn this observational pilot study, we aimed to evaluate the role of gallium-68-labelled DOTA-TATE (Ga-68-TATE) PET/computed tomography (CT) scanning in patients with multiple myeloma (MM), considering previous promising results obtained from conventional somatostatin receptor scintigraphy with In-111 pentetreotide.Materials and methodsTwenty-one patients with a diagnosis of MM were prospectively included in this study: eight patients were referred for initial staging and 13 patients for restaging purpose. Both fluorine-18 fluorodeoxyglucose (F-18-FDG) and TATE PET/CT scanning were performed in all patients.ResultsAll patients had one or more PET-positive lesion on either F-18-FDG or TATE scans. Six patients had an additional diffusely increased bone marrow activity on F-18-FDG scans, five of whom also had a concordant bone marrow appearance on TATE scans. Each PET set (either F-18-FDG or TATE) was positive in 19 patients. There was a discordant result in four (19%) patients between F-18-FDG and TATE scans. F-18-FDG scans showed 112 lesions (86 TATE-positive; 26 TATE-negative) in 19 patients, whereas TATE scans showed 108 lesions (86 F-18-FDG-positive; 22 F-18-FDG-negative) in 19 patients. No significant difference was found between the two modalities in terms of lesion numbers detected (P=0.67). However, the presence of diffuse bone marrow uptake of TATE seems to be a predicting factor for the overall survival (P=0.033, hazard ratio: 15.2 and 95% confidence interval: 1.2-185.5).ConclusionTATE PET/CT seems to be an alternative imaging modality and may play a complementary role in MM management, at least by providing a different pathobiological insight into the disease.

| Düzce Üniversitesi | Kütüphane | Açık Erişim Politikası | Rehber | OAI-PMH |

Bu site Creative Commons Alıntı-Gayri Ticari-Türetilemez 4.0 Uluslararası Lisansı ile korunmaktadır.


Düzce Üniversitesi, Kütüphane ve Dokümantasyon Daire Başkanlığı, Düzce, TÜRKİYE
İçerikte herhangi bir hata görürseniz lütfen bize bildirin

DSpace 7.6.1, Powered by İdeal DSpace

DSpace yazılımı telif hakkı © 2002-2025 LYRASIS

  • Çerez Ayarları
  • Gizlilik Politikası
  • Son Kullanıcı Sözleşmesi
  • Geri Bildirim